Legend Biotech Corporation (NASDAQ:LEGN) Q2 2025 Earnings Call Transcript August 11, 2025
Legend Biotech Corporation misses on earnings expectations. Reported EPS is $-0.34 EPS, expectations were $-0.22.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn your conference over to Caroline Paul, Associate Director of...
